Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NANCY HOLEKAMP

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1831197557
CMS profile
173773
Location
CHESTERFIELD, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$269,216.80

185 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 185 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NANCY HOLEKAMP

NPI 1831197557 · CMS profile ID 173773

Allopathic & Osteopathic Physicians / Ophthalmology

CHESTERFIELD, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 185 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831197557?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NANCY HOLEKAMP, NPI 1831197557, CMS profile ID 173773. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 185 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831197557?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). NANCY HOLEKAMP, NPI 1831197557, CMS profile ID 173773. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 185 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831197557?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
NANCY HOLEKAMP, NPI 1831197557, CMS profile ID 173773, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 185 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1831197557?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

185 matching records · $269,216.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 185 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 185.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech, Inc. $377.4806/28/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681176039 CMS
Allergan Inc. $10.0506/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541021 CMS
Regeneron Healthcare Solutions, Inc. $1,022.0006/06/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394639 CMS
Alcon Vision LLC $13.4206/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 665786599 CMS
Allergan Inc. $8.2105/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541019 CMS
Genentech, Inc. $238.5805/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681167035 CMS
Genentech, Inc. $936.9805/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681169753 CMS
Genentech, Inc. $296.1105/17/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681170388 CMS
Genentech, Inc. $6,600.0005/17/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681174901 CMS
Novartis Pharmaceuticals Corporation $19.9005/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659669043 CMS
Allergan Inc. $206.3805/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540982 CMS
Allergan Inc. $151.9805/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540985 CMS
Allergan Inc. $9,500.0005/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540989 CMS
Allergan Inc. $169.8605/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540995 CMS
Allergan Inc. $36.8905/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540997 CMS
Allergan Inc. $38.1605/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541000 CMS
Allergan Inc. $11.6605/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541005 CMS
Allergan Inc. $116.2705/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541009 CMS
Allergan Inc. $55.9705/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670541011 CMS
Alimera Sciences, Inc. $22.9605/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691752859 CMS
Spark Therapeutics, Inc. $217.8205/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682146081 CMS
Spark Therapeutics, Inc. $459.1005/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682146083 CMS
Spark Therapeutics, Inc. $65.7505/07/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682146085 CMS
Spark Therapeutics, Inc. $6,200.0005/07/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682146087 CMS
Spark Therapeutics, Inc. $97.0805/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 682146089 CMS
Genentech USA, Inc. $19.0705/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681273479 CMS
Genentech, Inc. $51.3904/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681175247 CMS
F. Hoffmann-La Roche AG $2,520.0004/28/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681073387 CMS
F. Hoffmann-La Roche AG $53.1604/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681075389 CMS
Allergan Inc. $1,125.0004/27/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540977 CMS
Genentech, Inc. $61.0004/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681162341 CMS
Novartis Pharmaceuticals Corporation $29.7104/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659669041 CMS
Allergan Inc. $7.3304/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540971 CMS
Allergan Inc. $6,750.0004/13/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540965 CMS
Regeneron Healthcare Solutions, Inc. $4,080.0004/11/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394637 CMS
Regeneron Healthcare Solutions, Inc. $8,176.0004/08/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394635 CMS
Regeneron Healthcare Solutions, Inc. $84.3404/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394633 CMS
Allergan Inc. $8.3304/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670540963 CMS
Novartis Pharmaceuticals Corporation $5,040.0004/04/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 659669047 CMS
Regeneron Healthcare Solutions, Inc. $122.6004/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394631 CMS
F. Hoffmann-La Roche AG $8,510.0003/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681069499 CMS
F. Hoffmann-La Roche AG $3,037.5003/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681070001 CMS
F. Hoffmann-La Roche AG $571.0003/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681073551 CMS
F. Hoffmann-La Roche AG $12,150.0003/31/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681074853 CMS
Genentech USA, Inc. $306.4203/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681163068 CMS
Genentech USA, Inc. $745.5803/30/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681261971 CMS
Genentech USA, Inc. $2,450.0003/30/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681321505 CMS
Genentech USA, Inc. $376.4303/30/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681339187 CMS
Alimera Sciences, Inc. $20.4403/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 691752853 CMS
Regeneron Healthcare Solutions, Inc. $682.0003/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673394629 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $269,216.80 185
PY2020 $159,312.24 90
PY2021 $134,541.13 72
PY2022 $201,501.25 146
PY2023 $3,150.00 2
PY2025 $300.00 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Recipient $15,906.50 16
PY2024 Principal investigator $7,193.00 3
PY2023 Recipient $849.33 1
PY2023 Principal investigator $40,360.46 22
PY2022 Recipient $2,396.92 4
PY2022 Principal investigator $407,201.66 70
PY2021 Recipient $12,351.37 4
PY2021 Principal investigator $617,159.07 86
PY2020 Recipient $31,434.75 3
PY2020 Principal investigator $564,474.34 54
PY2019 Principal investigator $309,202.31 33

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient F. Hoffmann-La Roche AG $827.20 12/31/2024 Covered Recipient Physician The Impact of Continuous Delivery of Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362779
Recipient F. Hoffmann-La Roche AG $674.00 12/31/2024 Covered Recipient Physician The Impact of Continuous Delivery of Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362781
Recipient F. Hoffmann-La Roche AG $685.71 12/31/2024 Covered Recipient Physician Function & Anatomy Fibrosis, MA, and fluid [Combo] No dispute reported 06/30/2026 1133362783
Recipient F. Hoffmann-La Roche AG $960.00 09/30/2024 Covered Recipient Physician Surgical Video Analysis in PDS clinical trials: Lessons learned No dispute reported 06/30/2026 1133362763
Recipient F. Hoffmann-La Roche AG $1,604.17 09/30/2024 Covered Recipient Physician Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants No dispute reported 06/30/2026 1133362765
Recipient F. Hoffmann-La Roche AG $561.67 09/30/2024 Covered Recipient Physician Characterisation of Fibrosis in the Archway Trial: The Effect of Continuous Delivery of Ranibizumab via the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362767
Recipient F. Hoffmann-La Roche AG $1,654.40 09/30/2024 Covered Recipient Physician Clinical Benefits of Continuous Delivery of Anti-VEGF Ranibizumab with the Port Delivery System in Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362769
Recipient F. Hoffmann-La Roche AG $480.00 09/30/2024 Covered Recipient Physician Clinical Impact of the Port Delivery System With Ranibizumab (PDS) in Retinal Diseases No dispute reported 06/30/2026 1133362771
Recipient F. Hoffmann-La Roche AG $689.33 09/30/2024 Covered Recipient Physician Technical Updates to Port Delivery System With Ranibizumab (PDS) and Clinical Experience With Updated Refill Needle No dispute reported 06/30/2026 1133362773
Recipient F. Hoffmann-La Roche AG $800.00 09/30/2024 Covered Recipient Physician Clinical Benefits of Continuous Delivery of Anti-VEGF Ranibizumab with the Port Delivery System in Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362775
Recipient F. Hoffmann-La Roche AG $875.50 09/30/2024 Covered Recipient Physician The Impact of Continuous Delivery of Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362777
Recipient F. Hoffmann-La Roche AG $2,384.62 09/30/2024 Covered Recipient Physician VA2 PhIII Yosemite No dispute reported 06/30/2026 1133362789
Recipient F. Hoffmann-La Roche AG $1,181.67 06/30/2024 Covered Recipient Physician Caregiver Experience with anti-VEGF Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration: A multi-national quantitative study No dispute reported 06/30/2026 1133362785
Recipient F. Hoffmann-La Roche AG $1,312.50 06/30/2024 Covered Recipient Physician Patient Experience Survey Of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema No dispute reported 06/30/2026 1133362787
Recipient F. Hoffmann-La Roche AG $982.40 03/31/2024 Covered Recipient Physician Clinical Benefits of Continuous Delivery of Anti-VEGF Ranibizumab with the Port Delivery System in Neovascular Age-Related Macular Degeneration No dispute reported 06/30/2026 1133362759
Recipient F. Hoffmann-La Roche AG $233.33 03/31/2024 Covered Recipient Physician Technical Updates to Port Delivery System With Ranibizumab (PDS) and Clinical Experience With Updated Refill Needle No dispute reported 06/30/2026 1133362761
Principal investigator 1 Genentech, Inc. $6,450.00 02/07/2024 Non-covered Recipient Entity
MIDWEST VISION RESEARCH FOUNDATION
Post Marketing study to monitor safety of PDS with ranibizumab in patients with nAMD in real world No dispute reported 06/30/2026 1133404296
Principal investigator 1 Genentech, Inc. $643.00 02/07/2024 Non-covered Recipient Entity
MIDWEST VISION RESEARCH FOUNDATION
Post Marketing study to monitor safety of PDS with ranibizumab in patients with nAMD in real world No dispute reported 06/30/2026 1133404298
Principal investigator 1 Genentech, Inc. $100.00 02/06/2024 Non-covered Recipient Entity
MIDWEST VISION RESEARCH FOUNDATION
Phase 2 of RO7171009 in GA No dispute reported 06/30/2026 1133404350